Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/2/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Ronald A. Sherman

Wrong Dr. Ronald A. Sherman?

Board Member

Education & Research Foundation
Local Address: Irvine, California, United States
Education and Research Foundation for the SNM
6500 Appaloosa Ave. N
Forest Lake, Minnesota 55025
United States

 
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • MSc
  • medical degree
    UCLA
  • B.S. , Entomology
    UC Riverside
  • Masters Degree program in Clinical Tropical Medicine
    London School of Hygiene and Tropical Medicine
  • Diploma , Tropical Medicine and Hygiene
    Royal College of Physicians
  • B.S. , Entomology
    UC Riverside
150 Total References
Web References
Ronald A. Sherman, MD, MSc, ...
www.monarchlabs.com, 2 Oct 2013 [cached]
Ronald A. Sherman, MD, MSc, DTM&H Co-founder and Laboratory Director
Born in Los Angeles, Ronald Sherman earned his B.S. in Entomology at the University of California, Riverside, and his medical degree at UCLA. Between his internship in San Francisco, and his Internal Medicine Residency at UC Davis, he spent a year as a traveling general practitioner in Arizona, treating Native Americans, the Urban Poor, and the rural underserved. In 1988, Dr. Sherman completed the Masters Degree program in Clinical Tropical Medicine at the London School of Hygiene and Tropical Medicine, and also received his Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians. After returning to the US in 1989, he trained as an Infectious Diseases Fellow at UC Irvine, during which time he began his clinical studies of maggot therapy. Dr. Sherman continued those studies as a Geriatrics and Infectious Diseases staff physician at the VA Medical Center, Long Beach. In 1995, he left the Department of Veterans Affairs and joined the Faculty at UC Irvine. With NIH funding, Dr. Sherman worked closely with Michael Selsted's research team as he studied the biochemistry underlying the maggots' antimicrobial and wound-healing activity. Dr. Sherman continued his patient care activities by serving as an HIV/AIDS specialist for the Orange County Health Care Agency 1 or 2 days per week, where he serves to this day. In 2003, Dr. Sherman co-founded the BioTherapeutics, Education & Research (BTER) Foundation, a public charity whose mission is to advance health care through education and research in maggot therapy, leech therapy, and the other biotherapeutic modalities. He currently functions as its Board Chair and Director. Since 2004, production and distribution of Dr. Sherman's Medical Maggots has been regulated by the Food and Drug Administration. To meet the demand for maggots, and to uphold the high production standards required by the FDA, he co-founded Monarch Labs, for which he serves as the Laboratory's Director. Dr. Sherman left his position at the University of California in July, 2008, in order to pursue his interests in teaching and research in biotherapy, and to optimize the quality control of Medical Maggots at Monarch Labs.
Maggots Quickly Clean Up Wounds, Study Shows
news.healingwell.com, 12 Jan 2012 [cached]
"Twenty years ago, maggot therapy was performed mostly as a 'last resort' prior to amputation," for the treatment of non-healing wounds, explained Dr. Ronald A. Sherman, a "biotherapeutics" researcher at the University of California, Irvine, and the Los Angeles and Orange County health departments. He was not involved in the new study.
Sherman noted that past studies found that when used as a last resort (after antibiotics and surgery failed), maggot therapy eliminated the need for amputations in an estimated 40 to 60 percent of cases.
The treatment has gained ever-broader acceptance in recent years, with studies touting its safety record and effectiveness in less severe, non-emergency situations.
"(This) is one of those studies, and clearly supports those who include maggot therapy as part of their wound-care tool bag," Sherman said, by suggesting "that there is no reason to delay maggot therapy until the wound and underlying diseases have progressed."
...
Sherman, also director of the BioTherapeutics, Education & Research Foundation in Irvine, Calif., called the study "well-conceived" and "well-executed."
It "demonstrated that maggot therapy is safe and at least equally effective to conventional surgical wound care," he noted. "This is not a new finding, but their study is very important because it adds to our limited database on maggot therapy."
But Sherman also noted that more aspects of maggot therapy remain to be explored, such as the potential for so-called "free-range maggot therapy" in which bag-less larvae are placed in direct contact with the wound.
"While this is a powerful testament to the potency of the maggots' therapeutic secretions, we are still left wondering whether or not free-range maggots might have done any better," he said. But this, he noted, awaits further study.
...
SOURCES: Ronald A. Sherman, M.D., director, BioTherapeutics, Education & Research Foundation, co-founder and laboratory director, Monarch Labs, and researcher, University of California, Irvine and the Los Angeles and Orange County health departments, Irvine, Calif.; Dec. 19, 2011 (online), Archives of Dermatology
"March 2009" Archives - Orange County News - Navel Gazing
blogs.ocweekly.com, 1 Mar 2009 [cached]
Writer Paul Oginnicatches readers up on former UC Irvine professor Ronald A. Sherman in the latest issue of New University, UCI's student newspaper. Sherman, the medical director at Monarch Labs and founder of the nonprofit BioTherapeutics, Education & Research Foundation, is now making new headlines with an old technique: maggot therapy.
Although the practice of maggot treatment dates back many centuries, recent scientific studies generated by Sherman have spawned a renewed interest in the procedure.
News from the BTER Foundation
www.bterfoundation.org, 8 Feb 2012 [cached]
In April, BTER Foundation Board Members Ronald Sherman of Irvine, California, and Pamela Mitchell from Akron, Ohio, were invited to appear at a public hearing at Medicare's Baltimore headquarters.
...
In a letter received today by Dr. Sherman, Director of the BTER Foundation and Laboratory Director for Monarch Labs (producer of Medical Maggots™ brand of medicinal maggots), CMS officials announced their collaborative work with AMA, and the publication of their coding recommendations in CPT® Assistant.
...
"It's strange, but many insurance companies will pay tens of thousands of dollars for an amputation, probably because it is so common now-a-days, but will hesitate or object to paying $100 for a course of maggot therapy," said Dr. Sherman, "even though studies repeatedly demonstrate that medicinal maggots have saved 40-50% of limbs otherwise scheduled for amputation due to non-healing wounds. It's no wonder that more and more patients are demanding that their doctors try maggot therapy, even when patients are asked to pay for the treatments themselves.
Dr. Sherman added: "The timing of this recommendation, just before Veteran's Day, does not go unnoticed.
...
Dr. Sherman's own clinical studies ere performed during the 1990's at the Veterans Affairs Medical Center in Long Beach, California, with funding from the Paralyzed Veterans of America.
...
Ronald Sherman, Director
...
Ronald A. Sherman
...
Ronald A Sherman (Chair); Randall Sullivan (Secretary);
They got a big boost in ...
www.fortwayne.com, 5 Nov 2012 [cached]
They got a big boost in 2004, when the Food and Drug Administration approved medicinal leeches and maggots, and the use of both continues to grow, said Dr. Ron Sherman, director of the Biotherapeutics Education and Research Foundation, a nonprofit based in Irvine, Calif.
"I don't believe that they have seen their full use nor do I see us anywhere near the plateau for the clinical utilities of maggots or leeches," Sherman told The Indianapolis Star for a Sunday story.
Exact numbers are hard to come by because the labs that produce leeches and maggots do not publicize their sales data. However, Sherman said, in 1990, only one lab marketed medical-grade maggots.
...
But the "yuck" factor is only one thing that stands in the way of broader use of these biotherapies, Sherman said.
Lack of education about why they're being used can certainly contribute. So can the low-tech nature of this treatment. It's hard to imagine that a hospital performing the latest in robotics surgery would also offer this decidedly non-glitzy therapy, Sherman said.
Many hospitals "have not yet overcome the worries that people will think poorly of them if they're using an old therapy," he said.
Other People with the name "Sherman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304